109 related articles for article (PubMed ID: 27479640)
1. Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients.
O'Neill AC; Somarouthu B; Tirumani SH; Braschi-Amirfarzan M; Van den Abbeele AD; Ramaiya NH; Shinagare AB
Radiology; 2017 Jan; 282(1):160-170. PubMed ID: 27479640
[TBL] [Abstract][Full Text] [Related]
2. Advanced High-Grade Serous Ovarian Cancer: Frequency and Timing of Thoracic Metastases and the Implications for Chest Imaging Follow-up.
Shinagare AB; O'Neill AC; Cheng S; Somarouthu B; Tirumani SH; Nishino M; Van den Abbeele AD; Ramaiya NH
Radiology; 2015 Dec; 277(3):733-40. PubMed ID: 26053310
[TBL] [Abstract][Full Text] [Related]
3. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion.
Akin O; Sala E; Moskowitz CS; Ishill N; Soslow RA; Chi DS; Hricak H
Radiology; 2008 Aug; 248(2):511-7. PubMed ID: 18519739
[TBL] [Abstract][Full Text] [Related]
4. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer.
McIntosh LJ; O'Neill AC; Bhanusupriya S; Matalon SA; Van den Abbeele AD; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2017 Oct; 42(10):2513-2520. PubMed ID: 28429056
[TBL] [Abstract][Full Text] [Related]
6. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
7. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Patterns of Solitary Fibrous Tumors: A Single-Institution Experience.
O'Neill AC; Tirumani SH; Do WS; Keraliya AR; Hornick JL; Shinagare AB; Ramaiya NH
AJR Am J Roentgenol; 2017 Jan; 208(1):2-9. PubMed ID: 27762594
[TBL] [Abstract][Full Text] [Related]
9. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.
Bacalbasa N; Dima S; Brasoveanu V; David L; Balescu I; Purnichescu-Purtan R; Popescu I
World J Surg Oncol; 2015 Aug; 13():235. PubMed ID: 26243426
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.
Lim MC; Kang S; Lee KS; Han SS; Park SJ; Seo SS; Park SY
Gynecol Oncol; 2009 Jan; 112(1):28-34. PubMed ID: 19010521
[TBL] [Abstract][Full Text] [Related]
11. Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Morris PG; Ulaner GA; Eaton A; Fazio M; Jhaveri K; Patil S; Evangelista L; Park JY; Serna-Tamayo C; Howard J; Larson S; Hudis CA; McArthur HL; Jochelson MS
Cancer; 2012 Nov; 118(22):5454-62. PubMed ID: 22517371
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
[TBL] [Abstract][Full Text] [Related]
13. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer.
Krakora GA; Coakley FV; Williams G; Yeh BM; Breiman RS; Qayyum A
Radiology; 2004 Dec; 233(3):667-73. PubMed ID: 15516602
[TBL] [Abstract][Full Text] [Related]
14. Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Vargas HA; Huang EP; Lakhman Y; Ippolito JE; Bhosale P; Mellnick V; Shinagare AB; Anello M; Kirby J; Fevrier-Sullivan B; Freymann J; Jaffe CC; Sala E
Radiology; 2017 Nov; 285(2):482-492. PubMed ID: 28641043
[TBL] [Abstract][Full Text] [Related]
15. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
[TBL] [Abstract][Full Text] [Related]
16. Hepatic tumors: region-of-interest versus volumetric analysis for quantification of attenuation at CT.
Chalian H; Tochetto SM; Töre HG; Rezai P; Yaghmai V
Radiology; 2012 Mar; 262(3):853-61. PubMed ID: 22357887
[TBL] [Abstract][Full Text] [Related]
17. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
18. Advanced lung adenocarcinoma harboring a mutation of the epidermal growth factor receptor: CT findings after tyrosine kinase inhibitor therapy.
Choi CM; Kim MY; Lee JC; Kim HJ
Radiology; 2014 Feb; 270(2):574-82. PubMed ID: 24086072
[TBL] [Abstract][Full Text] [Related]
19. Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.
Vargas HA; Miccò M; Hong SI; Goldman DA; Dao F; Weigelt B; Soslow RA; Hricak H; Levine DA; Sala E
Radiology; 2015 Mar; 274(3):742-51. PubMed ID: 25383459
[TBL] [Abstract][Full Text] [Related]
20. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer.
Khalil HI; Patterson SA; Panicek DM
Radiology; 2005 Jun; 235(3):872-8. PubMed ID: 15833992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
